BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2023 7:44:15 AM | Browse: 410 | Download: 770
Publication Name World Journal of Transplantation
Manuscript ID 87636
Country Nepal
Received
2023-08-20 03:28
Peer-Review Started
2023-08-20 03:28
First Decision by Editorial Office Director
2023-09-29 02:47
Return for Revision
2023-09-29 02:47
Revised
2023-11-01 18:10
Publication Fee Transferred
Second Decision by Editor
2023-11-13 05:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2023-11-17 08:59
Articles in Press
2023-11-17 08:59
Edit the Manuscript by Language Editor
2023-11-10 05:46
Typeset the Manuscript
2023-12-13 13:55
Publish the Manuscript Online
2023-12-18 07:44
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Minireviews
Article Title Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection
Manuscript Source Invited Manuscript
All Author List Sumit Acharya, Suraj Lama and Durga Anil Kanigicherla
ORCID
Author(s) ORCID Number
Suraj Lama http://orcid.org/0000-0002-9814-7857
Funding Agency and Grant Number
Corresponding Author Suraj Lama, MBBS, MMed, PhD, Doctor, Doctor, Department of Nephrology, Shahid Dharmabhakta National Transplant Center, Dudhpati 1, Bhaktapur, Nepal, Bhaktapur 44800, Nepal. suraj_bhaju@yahoo.com
Key Words Anti-thymocyte globulin; T-cell-mediated rejection; Steroid-resistant rejection; Biopsy confirmed acute rejection
Core Tip Core Tip: Anti-thymocyte globulin is a highly efficient induction agent that can prevent acute rejection and delayed graft function. It is widely used for biopsy confirmed acute rejection reversal and steroid-resistant rejection.
Publish Date 2023-12-18 07:44
Citation Acharya S, Lama S, Kanigicherla DA. Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection. World J Transplant 2023; 13(6): 299-308
URL https://www.wjgnet.com/2220-3230/full/v13/i6/299.htm
DOI https://dx.doi.org/10.5500/wjt.v13.i6.299
Full Article (PDF) WJT-13-299-with-cover.pdf
Full Article (Word) WJT-13-299.docx
Manuscript File 87636_Auto_Edited-LJH_WangTQ-JLW.docx
Answering Reviewers 87636-Answering reviewers.pdf
Audio Core Tip 87636-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 87636-Conflict-of-interest statement.pdf
Copyright License Agreement 87636-Copyright license agreement.pdf
Peer-review Report 87636-Peer-review(s).pdf
Scientific Misconduct Check 87636-Bing-Liu JH-2.png
Scientific Misconduct Check 87636-CrossCheck.png
Scientific Editor Work List 87636-Scientific editor work list.pdf
CrossCheck Report 87636-CrossCheck report.pdf